Int J Oncol 52: [Related article:] 1603-1612, 2018; DOI:
10.3892/ijo.2018.4313
Following the publication of this article, the
authors have realized that Table I
was not included with the printed version of the article, although
it was referenced in the text. Subsequently, it has been determined
that a processing error or oversight must have been made during the
pre-press stages.
 | Table IClinical and pathological factors
associated with KCNQ1OT1 expression in 50 patients with HCC. |
Table I
Clinical and pathological factors
associated with KCNQ1OT1 expression in 50 patients with HCC.
| Clinical
characteristic | KCNQ1OT1 expression
| Chi-square | P-value |
|---|
| Low (n=22) | High (n=28) |
|---|
| Gender | | | | |
| Male | 12 | 18 | 0.487 | 0.485 |
| Female | 10 | 10 | | |
| Age (year) | | | | |
| <50 | 9 | 17 | 1.936 | 0.164 |
| ≥50 | 13 | 11 | | |
| HBsAg | | | | |
| Negative | 9 | 6 | 2.226 | 0.136 |
| Positive | 13 | 22 | | |
| Liver cirrhosis | | | | |
| Absent | 14 | 9 | 4.919 | 0.027* |
| Present | 8 | 19 | | |
| Serum AFP
(ng/ml) | | | | |
| <400 | 10 | 7 | 2.297 | 0.130 |
| ≥400 | 12 | 21 | | |
| Edmondson-Steiner
grading | | | | |
| I+II | 15 | 12 | 3.181 | 0.075 |
| III+IV | 7 | 16 | | |
| Tumor size | | | | |
| <5 cm | 18 | 9 | 12.239 | <0.001* |
| ≥5 cm | 4 | 19 | | |
| Venous
infiltration | | | | |
| Absent | 17 | 15 | 3.004 | 0.083 |
| Present | 5 | 13 | | |
| TNM stage | | | | |
| I + II | 15 | 7 | 9.323 | 0.002* |
| III + IV | 7 | 21 | | |
Table I, as it
should have appeared in this paper, is shown in the next page. We
apologize to the authors for this omission, and regret the
inconvenience that this has caused.
| Table IClinical and pathological factors
associated with KCNQ1OT1 expression in 50 patients with HCC. |
Table I
Clinical and pathological factors
associated with KCNQ1OT1 expression in 50 patients with HCC.
| Clinical
characteristic | KCNQ1OT1 expression
| Chi-square | P-value |
|---|
| Low (n=22) | High (n=28) |
|---|
| Gender | | | | |
| Male | 12 | 18 | 0.487 | 0.485 |
| Female | 10 | 10 | | |
| Age (year) | | | | |
| <50 | 9 | 17 | 1.936 | 0.164 |
| ≥50 | 13 | 11 | | |
| HBsAg | | | | |
| Negative | 9 | 6 | 2.226 | 0.136 |
| Positive | 13 | 22 | | |
| Liver cirrhosis | | | | |
| Absent | 14 | 9 | 4.919 | 0.027* |
| Present | 8 | 19 | | |
| Serum AFP
(ng/ml) | | | | |
| <400 | 10 | 7 | 2.297 | 0.130 |
| ≥400 | 12 | 21 | | |
| Edmondson-Steiner
grading | | | | |
| I+II | 15 | 12 | 3.181 | 0.075 |
| III+IV | 7 | 16 | | |
| Tumor size | | | | |
| <5 cm | 18 | 9 | 12.239 | <0.001* |
| ≥5 cm | 4 | 19 | | |
| Venous
infiltration | | | | |
| Absent | 17 | 15 | 3.004 | 0.083 |
| Present | 5 | 13 | | |
| TNM stage | | | | |
| I + II | 15 | 7 | 9.323 | 0.002* |
| III + IV | 7 | 21 | | |
